Bristol Short Term Investments vs Net Debt Analysis

BMY Stock  USD 58.78  0.09  0.15%   
Bristol Myers financial indicator trend analysis is way more than just evaluating Bristol Myers Squibb prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bristol Myers Squibb is a good investment. Please check the relationship between Bristol Myers Short Term Investments and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Short Term Investments vs Net Debt

Short Term Investments vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bristol Myers Squibb Short Term Investments account and Net Debt. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Bristol Myers' Short Term Investments and Net Debt is -0.02. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Net Debt in the same time period over historical financial statements of Bristol Myers Squibb, assuming nothing else is changed. The correlation between historical values of Bristol Myers' Short Term Investments and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of Bristol Myers Squibb are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Short Term Investments i.e., Bristol Myers' Short Term Investments and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.02
Relationship DirectionNegative 
Relationship StrengthInsignificant

Short Term Investments

Short Term Investments is an item under the current assets section of Bristol Myers balance sheet. It contains any investments Bristol Myers Squibb undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Bristol Myers Squibb can easily liquidate in the marketplace.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Bristol Myers' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bristol Myers Squibb current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
At this time, Bristol Myers' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 12.19 in 2024, whereas Selling General Administrative is likely to drop slightly above 3.6 B in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit36.4B36.0B34.3B36.0B
Total Revenue46.4B46.2B45.0B47.3B

Bristol Myers fundamental ratios Correlations

0.980.840.930.890.780.98-0.070.90.990.520.830.760.970.450.990.820.020.880.990.70.940.850.960.60.88
0.980.830.920.840.791.0-0.160.940.970.380.880.820.980.520.990.76-0.040.890.990.760.950.890.940.570.91
0.840.830.970.560.710.85-0.170.720.80.570.650.830.850.450.810.490.160.650.870.820.910.720.680.610.78
0.930.920.970.70.80.93-0.070.810.890.520.750.880.950.410.90.660.070.730.940.870.970.840.790.660.85
0.890.840.560.70.750.840.130.790.910.410.730.50.820.440.880.90.020.820.850.430.760.730.930.620.81
0.780.790.710.80.750.790.280.730.760.190.70.770.840.410.780.64-0.010.530.80.750.790.780.70.850.85
0.981.00.850.930.840.79-0.170.90.980.420.830.820.980.520.990.77-0.020.890.990.760.930.890.940.560.91
-0.07-0.16-0.17-0.070.130.28-0.17-0.12-0.07-0.11-0.07-0.11-0.03-0.62-0.120.170.23-0.45-0.11-0.06-0.05-0.16-0.130.44-0.14
0.90.940.720.810.790.730.9-0.120.870.210.980.780.90.480.920.66-0.110.830.910.690.910.850.870.570.84
0.990.970.80.890.910.760.98-0.070.870.530.80.710.950.460.990.840.00.890.980.650.910.830.980.570.86
0.520.380.570.520.410.190.42-0.110.210.530.120.160.380.180.450.480.150.440.480.180.450.180.440.210.35
0.830.880.650.750.730.70.83-0.070.980.80.120.760.840.410.850.6-0.170.740.840.670.870.80.80.580.78
0.760.820.830.880.50.770.82-0.110.780.710.160.760.880.350.760.48-0.240.580.80.970.860.870.620.530.8
0.970.980.850.950.820.840.98-0.030.90.950.380.840.880.40.970.78-0.040.810.980.830.950.90.90.630.89
0.450.520.450.410.440.410.52-0.620.480.460.180.410.350.40.50.2-0.120.690.480.290.40.520.50.270.64
0.990.990.810.90.880.780.99-0.120.920.990.450.850.760.970.50.8-0.010.90.990.690.930.860.970.580.88
0.820.760.490.660.90.640.770.170.660.840.480.60.480.780.20.8-0.020.720.780.450.690.650.850.520.75
0.02-0.040.160.070.02-0.01-0.020.23-0.110.00.15-0.17-0.24-0.04-0.12-0.01-0.02-0.120.01-0.190.07-0.25-0.030.23-0.12
0.880.890.650.730.820.530.89-0.450.830.890.440.740.580.810.690.90.72-0.120.870.490.770.780.940.30.81
0.990.990.870.940.850.80.99-0.110.910.980.480.840.80.980.480.990.780.010.870.750.960.870.940.610.89
0.70.760.820.870.430.750.76-0.060.690.650.180.670.970.830.290.690.45-0.190.490.750.820.830.540.560.75
0.940.950.910.970.760.790.93-0.050.910.910.450.870.860.950.40.930.690.070.770.960.820.850.840.680.86
0.850.890.720.840.730.780.89-0.160.850.830.180.80.870.90.520.860.65-0.250.780.870.830.850.820.530.84
0.960.940.680.790.930.70.94-0.130.870.980.440.80.620.90.50.970.85-0.030.940.940.540.840.820.50.83
0.60.570.610.660.620.850.560.440.570.570.210.580.530.630.270.580.520.230.30.610.560.680.530.50.64
0.880.910.780.850.810.850.91-0.140.840.860.350.780.80.890.640.880.75-0.120.810.890.750.860.840.830.64
Click cells to compare fundamentals

Bristol Myers Account Relationship Matchups

Bristol Myers fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets129.9B118.5B109.3B96.8B95.2B99.9B
Short Long Term Debt Total47.5B51.7B45.6B40.7B41.5B43.5B
Other Current Liab7.9B13.2B13.0B13.5B14.4B15.1B
Total Current Liabilities18.3B19.1B21.9B21.9B22.3B23.4B
Total Stockholder Equity51.6B37.8B35.9B31.1B29.4B15.0B
Property Plant And Equipment Net6.3B6.7B7.0B7.5B8.0B5.2B
Net Debt35.2B37.1B31.6B31.6B30B31.5B
Retained Earnings34.5B21.3B23.8B25.5B28.8B22.0B
Cash12.3B14.5B14.0B9.1B11.5B12.0B
Non Current Assets Total100.6B88.3B76.1B69.5B63.4B66.6B
Non Currrent Assets Other6.6B2.1B1.7B1.0B1.8B1.9B
Cash And Short Term Investments12.3B14.5B14.0B9.1B12.3B12.9B
Net Receivables7.7B8.5B12.5B13.9B15.3B16.0B
Good Will22.5B20.5B20.5B21.1B21.2B22.2B
Common Stock Shares Outstanding1.7B2.3B2.2B2.1B2.1B1.6B
Liabilities And Stockholders Equity129.9B118.5B109.3B96.8B95.2B99.9B
Non Current Liabilities Total59.9B61.5B51.4B43.8B43.4B45.6B
Inventory4.3B2.1B2.1B2.3B2.7B1.9B
Other Current Assets2.0B5.6B1.3B1.7B1.6B2.0B
Other Stockholder Equity18.4B18.1B13.1B6.5B1.9B2.0B
Total Liab78.2B80.6B73.3B65.7B65.7B69.0B
Property Plant And Equipment Gross6.3B5.9B11.0B11.6B12.8B13.5B
Total Current Assets29.4B30.2B33.3B27.3B31.8B33.4B
Accumulated Other Comprehensive Income(1.5B)(1.8B)(1.3B)(1.3B)(1.5B)(1.6B)
Short Term Debt3.5B2.5B5.1B4.4B3.3B3.4B
Intangible Assets64.0B53.2B42.8B36.4B27.1B28.4B
Accounts Payable2.4B2.7B2.9B3.0B3.3B1.9B
Short Term Investments3.0B1.3B3.2B130M816M775.2M
Other Liab15.9B12.3B11.0B7.4B8.5B4.9B
Other Assets4.8B7.3B3.3B2.9B3.3B3.3B
Long Term Debt43.4B48.3B39.6B35.1B36.7B38.5B
Treasury Stock(25.4B)(26.2B)(31.3B)(38.6B)(43.8B)(41.6B)
Property Plant Equipment6.3B5.9B6.0B6.3B7.2B5.8B
Current Deferred Revenue4.5B3.6B3.7B1.3B8.4B8.8B
Net Tangible Assets(34.9B)(36.0B)(28.2B)(25.9B)(23.4B)(22.2B)
Noncontrolling Interest In Consolidated Entity96M100M60M57M55M74.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.